$CSBR
CHAMPIONS ONCOLOGY, INC.

2021 Q1 Form 10-Q Financial Statement

#000162828021004710 Filed on March 15, 2021

View on sec.gov

Income Statement

Concept 2021 Q1 2020 Q2 2020 Q1
Revenue $10.81M $8.750M $9.012M
YoY Change 19.97% 13.34% 40.16%
Cost Of Revenue $4.623M $4.920M $4.325M
YoY Change 6.89% 14.42% 26.13%
Gross Profit $6.189M $3.820M $4.687M
YoY Change 32.05% 11.7% 56.18%
Gross Profit Margin 57.24% 43.66% 52.01%
Selling, General & Admin $3.328M $3.580M $2.863M
YoY Change 16.24% 56.33% 36.2%
% of Gross Profit 53.77% 93.72% 61.08%
Research & Development $1.879M $1.820M $1.391M
YoY Change 35.08% 45.6% 9.61%
% of Gross Profit 30.36% 47.64% 29.68%
Depreciation & Amortization $279.0K $250.0K $184.0K
YoY Change 51.63% 38.89% 44.88%
% of Gross Profit 4.51% 6.54% 3.93%
Operating Expenses $5.207M $5.400M $8.579M
YoY Change -39.31% 52.54% 26.16%
Operating Profit $982.0K -$1.580M $433.0K
YoY Change 126.79% 1216.67% -217.03%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net -$8.000K -$40.00K -$14.00K
YoY Change -42.86% 33.33% -1500.0%
Pretax Income $974.0K -$1.960M $419.0K
YoY Change 132.46% 1206.67% -213.55%
Income Tax $15.00K $90.00K $12.00K
% Of Pretax Income 1.54% 2.86%
Net Earnings $959.0K -$2.050M $75.00K
YoY Change 1178.67% 720.0% -120.33%
Net Earnings / Revenue 8.87% -23.43% 0.83%
Basic Earnings Per Share $0.07 $0.03
Diluted Earnings Per Share $0.07 -$165.2K $0.03
COMMON SHARES
Basic Shares Outstanding 13.37M shares 11.75M shares
Diluted Shares Outstanding 14.51M shares 13.67M shares

Balance Sheet

Concept 2021 Q1 2020 Q2 2020 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $7.430M $8.340M $3.280M
YoY Change 126.52% 157.41% -0.91%
Cash & Equivalents $7.400M $8.342M $3.282M
Short-Term Investments
Other Short-Term Assets $420.0K $390.0K $360.0K
YoY Change 16.67% 25.81% 20.0%
Inventory
Prepaid Expenses
Receivables $6.121M $4.770M $4.493M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $13.97M $13.50M $8.130M
YoY Change 71.82% 70.37% 8.01%
LONG-TERM ASSETS
Property, Plant & Equipment $5.540M $3.993M $3.246M
YoY Change 70.67% 56.83% 25.91%
Goodwill $335.0K $335.0K $669.0K
YoY Change -49.93% -49.93% 0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $36.00K $128.0K $128.0K
YoY Change -71.88% 0.0% -6.57%
Total Long-Term Assets $11.29M $7.254M $6.945M
YoY Change 62.58% 116.99% 105.23%
TOTAL ASSETS
Total Short-Term Assets $13.97M $13.50M $8.130M
Total Long-Term Assets $11.29M $7.254M $6.945M
Total Assets $25.26M $20.75M $15.08M
YoY Change 67.56% 84.21% 38.16%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.745M $3.140M $2.215M
YoY Change -21.22% 11.86% 4.68%
Accrued Expenses $2.207M $2.721M $978.0K
YoY Change 125.66% 130.59% 52.57%
Deferred Revenue $6.615M $5.800M $4.586M
YoY Change 44.24% 44.21% -2.9%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00 $130.0K $180.0K
YoY Change -100.0% 550.0% -18.18%
Total Short-Term Liabilities $11.20M $12.30M $8.446M
YoY Change 32.55% 53.32% 9.63%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $181.0K $178.0K $151.0K
YoY Change 19.87% 17.88% 0.0%
Total Long-Term Liabilities $181.0K $178.0K $151.0K
YoY Change 19.87% 17.88% 0.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $11.20M $12.30M $8.446M
Total Long-Term Liabilities $181.0K $178.0K $151.0K
Total Liabilities $17.17M $15.65M $11.90M
YoY Change 44.34% 73.39% 38.54%
SHAREHOLDERS EQUITY
Retained Earnings -$71.64M -$72.89M -$70.60M
YoY Change 1.47% 3.1% 0.28%
Common Stock $79.72M $77.99M $73.80M
YoY Change 8.02% 6.93% 1.42%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $8.086M $5.099M $5.513M
YoY Change
Total Liabilities & Shareholders Equity $25.26M $20.75M $15.08M
YoY Change 67.56% 84.21% 38.16%

Cashflow Statement

Concept 2021 Q1 2020 Q2 2020 Q1
OPERATING ACTIVITIES
Net Income $959.0K -$2.050M $75.00K
YoY Change 1178.67% 720.0% -120.33%
Depreciation, Depletion And Amortization $279.0K $250.0K $184.0K
YoY Change 51.63% 38.89% 44.88%
Cash From Operating Activities $140.0K $2.550M $280.0K
YoY Change -50.0% 920.0% -76.86%
INVESTING ACTIVITIES
Capital Expenditures -$1.210M -$1.530M -$170.0K
YoY Change 611.76% 992.86% -15.0%
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change
Cash From Investing Activities -$1.210M -$1.530M -$170.0K
YoY Change 611.76% 992.86% -15.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -60.00K 4.040M 390.0K
YoY Change -115.38% -2226.32% 11.43%
NET CHANGE
Cash From Operating Activities 140.0K 2.550M 280.0K
Cash From Investing Activities -1.210M -1.530M -170.0K
Cash From Financing Activities -60.00K 4.040M 390.0K
Net Change In Cash -1.130M 5.060M 500.0K
YoY Change -326.0% -6425.0% -63.24%
FREE CASH FLOW
Cash From Operating Activities $140.0K $2.550M $280.0K
Capital Expenditures -$1.210M -$1.530M -$170.0K
Free Cash Flow $1.350M $4.080M $450.0K
YoY Change 200.0% 946.15% -68.09%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity File Number
EntityFileNumber
001-11504
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Central Index Key
EntityCentralIndexKey
0000771856
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--04-30
us-gaap Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
us-gaap:ServiceMember
CY2021Q1 us-gaap Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
us-gaap:ServiceMember
CY2020Q1 us-gaap Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
us-gaap:ServiceMember
us-gaap Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
us-gaap:ServiceMember
CY2021Q1 us-gaap Type Of Cost Good Or Service Extensible List
TypeOfCostGoodOrServiceExtensibleList
us-gaap:ServiceMember
CY2020Q1 us-gaap Type Of Cost Good Or Service Extensible List
TypeOfCostGoodOrServiceExtensibleList
us-gaap:ServiceMember
us-gaap Type Of Cost Good Or Service Extensible List
TypeOfCostGoodOrServiceExtensibleList
us-gaap:ServiceMember
us-gaap Type Of Cost Good Or Service Extensible List
TypeOfCostGoodOrServiceExtensibleList
us-gaap:ServiceMember
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2021-01-31
dei Document Transition Report
DocumentTransitionReport
false
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Shell Company
EntityShellCompany
false
dei Entity Registrant Name
EntityRegistrantName
CHAMPIONS ONCOLOGY, INC.
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
52-1401755
dei Entity Address Address Line1
EntityAddressAddressLine1
One University Plaza, Suite 307
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
07601
dei Entity Address City Or Town
EntityAddressCityOrTown
Hackensack
dei Entity Address State Or Province
EntityAddressStateOrProvince
NJ
dei City Area Code
CityAreaCode
201
dei Local Phone Number
LocalPhoneNumber
808-8400
dei Security12b Title
Security12bTitle
Common Stock, par value $0.001 per share
dei Trading Symbol
TradingSymbol
CSBR
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2021Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
13390172 shares
CY2021Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
7429000 USD
CY2020Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
8342000 USD
CY2021Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
6121000 USD
CY2020Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
4770000 USD
CY2021Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
419000 USD
CY2020Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
385000 USD
CY2021Q1 us-gaap Assets Current
AssetsCurrent
13969000 USD
CY2020Q2 us-gaap Assets Current
AssetsCurrent
13497000 USD
CY2021Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
5380000 USD
CY2020Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2798000 USD
CY2021Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
5540000 USD
CY2020Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3993000 USD
CY2021Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
36000 USD
CY2020Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
128000 USD
CY2021Q1 us-gaap Goodwill
Goodwill
335000 USD
CY2020Q2 us-gaap Goodwill
Goodwill
335000 USD
CY2021Q1 us-gaap Assets
Assets
25260000 USD
CY2020Q2 us-gaap Assets
Assets
20751000 USD
CY2021Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
1745000 USD
CY2020Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
3140000 USD
CY2021Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2426000 USD
CY2020Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2502000 USD
CY2021Q1 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
0 USD
CY2020Q2 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
125000 USD
CY2021Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
628000 USD
CY2020Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
503000 USD
CY2021Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
6615000 USD
CY2020Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
5815000 USD
CY2021Q1 us-gaap Liabilities Current
LiabilitiesCurrent
11414000 USD
CY2020Q2 us-gaap Liabilities Current
LiabilitiesCurrent
12085000 USD
CY2021Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
5798000 USD
CY2020Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
3170000 USD
CY2021Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
181000 USD
CY2020Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
178000 USD
CY2021Q1 us-gaap Liabilities
Liabilities
17393000 USD
CY2020Q2 us-gaap Liabilities
Liabilities
15433000 USD
CY2021Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2021Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2021Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
13390172 shares
CY2021Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
13390172 shares
CY2020Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
12726728 shares
CY2020Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
12726728 shares
CY2021Q1 us-gaap Common Stock Value
CommonStockValue
13000 USD
CY2020Q2 us-gaap Common Stock Value
CommonStockValue
13000 USD
CY2021Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
79711000 USD
CY2020Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
77978000 USD
CY2021Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-71857000 USD
CY2020Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-72673000 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
7867000 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
5318000 USD
CY2021Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
25260000 USD
CY2020Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
20751000 USD
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
10812000 USD
CY2020Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
9012000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
30476000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
23375000 USD
CY2021Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
4842000 USD
CY2020Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
4325000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
15822000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
11958000 USD
CY2021Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1879000 USD
CY2020Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1391000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5125000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4035000 USD
CY2021Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1492000 USD
CY2020Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1307000 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
4048000 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
3155000 USD
CY2021Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1836000 USD
CY2020Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1556000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4686000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4118000 USD
CY2021Q1 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
10049000 USD
CY2020Q1 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
8579000 USD
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
29681000 USD
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
23266000 USD
CY2021Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
763000 USD
CY2020Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
433000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
795000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
109000 USD
CY2021Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-8000 USD
CY2020Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-14000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
64000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1000 USD
CY2021Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
755000 USD
CY2020Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
419000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
859000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
110000 USD
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
15000 USD
CY2020Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
12000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
43000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
38000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
740000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
407000 USD
us-gaap Net Income Loss
NetIncomeLoss
816000 USD
us-gaap Net Income Loss
NetIncomeLoss
72000 USD
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.06
CY2020Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.03
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.06
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.01
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.05
CY2020Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.03
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.06
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.01
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13371613 shares
CY2020Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11752619 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12974470 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11653115 shares
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14507155 shares
CY2020Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
13673672 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14510280 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
13440861 shares
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
5318000 USD
CY2020Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
120000 USD
CY2020Q3 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
0 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
75000 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
5513000 USD
CY2020Q4 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
85000 USD
CY2020Q4 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
1294000 USD
CY2020Q4 us-gaap Net Income Loss
NetIncomeLoss
1000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
6893000 USD
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
232000 USD
CY2021Q1 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
2000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
740000 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
7867000 USD
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
2238000 USD
CY2019Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
131000 USD
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
-641000 USD
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
1728000 USD
CY2019Q4 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
77000 USD
CY2019Q4 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
2000 USD
CY2019Q4 us-gaap Net Income Loss
NetIncomeLoss
307000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
2114000 USD
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
229000 USD
CY2020Q1 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
427000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
407000 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
3177000 USD
us-gaap Net Income Loss
NetIncomeLoss
816000 USD
us-gaap Net Income Loss
NetIncomeLoss
72000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
437000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
437000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
881000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
579000 USD
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
0 USD
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
52000 USD
us-gaap Gain Loss On Termination Of Lease
GainLossOnTerminationOfLease
75000 USD
us-gaap Gain Loss On Termination Of Lease
GainLossOnTerminationOfLease
0 USD
csbr Increase Decrease In Operating Lease Right Of Use Assets
IncreaseDecreaseInOperatingLeaseRightOfUseAssets
226000 USD
csbr Increase Decrease In Operating Lease Right Of Use Assets
IncreaseDecreaseInOperatingLeaseRightOfUseAssets
299000 USD
csbr Reversalof Provisionfor Doubtful Accounts
ReversalofProvisionforDoubtfulAccounts
49000 USD
csbr Reversalof Provisionfor Doubtful Accounts
ReversalofProvisionforDoubtfulAccounts
218000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1401000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
334000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
34000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
47000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1395000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-913000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
97000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-202000 USD
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
3000 USD
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
0 USD
csbr Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
106000 USD
csbr Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
261000 USD
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
801000 USD
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
564000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
299000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
360000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2427000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
693000 USD
csbr Proceeds From Refund Of Security Deposit
ProceedsFromRefundOfSecurityDeposit
92000 USD
csbr Proceeds From Refund Of Security Deposit
ProceedsFromRefundOfSecurityDeposit
0 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2335000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-693000 USD
csbr Proceeds From Exercise Of Options And Warrants
ProceedsFromExerciseOfOptionsAndWarrants
1296000 USD
csbr Proceeds From Exercise Of Options And Warrants
ProceedsFromExerciseOfOptionsAndWarrants
429000 USD
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
173000 USD
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
51000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1123000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
378000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-913000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
45000 USD
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
8342000 USD
CY2019Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3237000 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
7429000 USD
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3282000 USD
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
3872000 USD
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
3205000 USD
csbr Non Cash Or Part Non Cash Acquisition Fixed Assets Acquired Unpaid Portion
NonCashOrPartNonCashAcquisitionFixedAssetsAcquiredUnpaidPortion
0 USD
csbr Non Cash Or Part Non Cash Acquisition Fixed Assets Acquired Unpaid Portion
NonCashOrPartNonCashAcquisitionFixedAssetsAcquiredUnpaidPortion
321000 USD
us-gaap Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
0 USD
us-gaap Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
160000 USD
csbr Numberof Operating Subsidiaries
NumberofOperatingSubsidiaries
2 subsidiary
CY2020Q2 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0 USD
CY2020Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11752619 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12974470 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11653115 shares
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.06
CY2020Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.03
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.06
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.01
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
740000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
407000 USD
us-gaap Net Income Loss
NetIncomeLoss
816000 USD
us-gaap Net Income Loss
NetIncomeLoss
72000 USD
CY2021Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
740000 USD
CY2020Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
407000 USD
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
816000 USD
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
72000 USD
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13371613 shares
CY2020Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11752619 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12974470 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11653115 shares
CY2021Q1 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
1135542 shares
CY2020Q1 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
1921053 shares
us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
1535810 shares
us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
1787746 shares
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14507155 shares
CY2020Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
13673672 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14510280 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
13440861 shares
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.05
CY2020Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.03
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.06
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.01
us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
3000 USD
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1693312 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4036371 shares
CY2021Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
181000 USD
CY2020Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
178000 USD
CY2021Q1 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0 USD
us-gaap Net Income Loss
NetIncomeLoss
816000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
299000 USD
CY2021Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-71900000 USD
CY2021Q1 csbr Working Capital Deficit
WorkingCapitalDeficit
2600000 USD
CY2021Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
7400000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
740000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
407000 USD
us-gaap Net Income Loss
NetIncomeLoss
816000 USD
us-gaap Net Income Loss
NetIncomeLoss
72000 USD
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13371613 shares
us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
3000 USD
csbr Unrecognized Tax Benefits Income Tax Penalties Anticipate Additional Unrecognized
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAnticipateAdditionalUnrecognized
4500 USD
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
15000 USD
CY2020Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
12000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
43000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
38000 USD
CY2021Q1 us-gaap Accounts Receivable Gross
AccountsReceivableGross
3333000 USD
CY2020Q2 us-gaap Accounts Receivable Gross
AccountsReceivableGross
2655000 USD
CY2021Q1 us-gaap Unbilled Contracts Receivable
UnbilledContractsReceivable
3126000 USD
CY2020Q2 us-gaap Unbilled Contracts Receivable
UnbilledContractsReceivable
2404000 USD
CY2021Q1 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
6459000 USD
CY2020Q2 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
5059000 USD
CY2021Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
338000 USD
CY2020Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
289000 USD
CY2021Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
6121000 USD
CY2020Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
4770000 USD
CY2021Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
6615000 USD
CY2020Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
5815000 USD
us-gaap Revenue Performance Obligation Description Of Timing
RevenuePerformanceObligationDescriptionOfTiming
The majority of the Company's revenue arrangements are service contracts that are complete within a year or less. There are a few contracts that range in duration between 1 and 3 years.
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
10812000 USD
CY2020Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
9012000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
30476000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
23375000 USD
CY2021Q1 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
9193000 USD
CY2020Q2 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
6765000 USD
CY2021Q1 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization
3653000 USD
CY2020Q2 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization
2772000 USD
CY2021Q1 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
5540000 USD
CY2020Q2 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
3993000 USD
CY2021Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
279000 USD
CY2020Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
184000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
757000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
491000 USD
CY2020Q2 us-gaap Finance Lease Right Of Use Asset Before Accumulated Amortization
FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization
343000 USD
CY2021Q1 us-gaap Finance Lease Right Of Use Asset Before Accumulated Amortization
FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization
343000 USD
CY2021Q1 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
18000 USD
CY2020Q1 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
35000 USD
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
124000 USD
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
88000 USD
csbr Finance Lease Cost
FinanceLeaseCost
149000 USD
CY2020Q1 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
2000 USD
CY2021Q1 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
0 USD
CY2018Q3 csbr Finance Lease Cost
FinanceLeaseCost
266000 USD
CY2018Q3 csbr Finance Lease Monthly Payment
FinanceLeaseMonthlyPayment
11000 USD
CY2019Q1 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
0 USD
CY2019Q4 csbr Finance Lease Number Of Right Of Use Assets Acquired
FinanceLeaseNumberOfRightOfUseAssetsAcquired
2 asset
CY2020 csbr Finance Lease Cost
FinanceLeaseCost
231000 USD
CY2021Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
232000 USD
CY2020Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
229000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
437000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
437000 USD
CY2021Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P3Y
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0012
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0157
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0180
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0012
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
2.56
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0039
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0157
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0180
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.7498
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.6914
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
0.7099
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.7264
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
0.7498
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.6914
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
0.7111
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
5.80
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
5.08
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
3.09
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2271658 shares
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
3.23
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
10663000 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
133833 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
9.21
csbr Share Based Compensation Arrangement By Share Based Payment Award Options Granted Weighted Average Remaining Contractual Term
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm
P7Y6M29D
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
663444 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
2.27
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
7000 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
6.43
csbr Share Based Compensation Arrangement By Share Based Payment Award Options Canceled In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCanceledInPeriod
35901 shares
csbr Share Based Compensation Arrangements By Share Based Payment Award Options Canceled In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsCanceledInPeriodWeightedAverageExercisePrice
4.03
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
5834 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
10.80
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1693312 shares
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
4.02
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y7M28D
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
11975000 USD
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
1693312 shares
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
4.02
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P5Y7M28D
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
11975000 USD
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1298688 shares
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
3.25
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P4Y11M4D
CY2021Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
10173000 USD
us-gaap Operating Lease Expense
OperatingLeaseExpense
941000 USD
us-gaap Operating Lease Expense
OperatingLeaseExpense
717000 USD
CY2021Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
312000 USD
CY2020Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
240000 USD
CY2021Q1 us-gaap Lessee Operating Lease Renewal Term
LesseeOperatingLeaseRenewalTerm
P6M
CY2021Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
5380000 USD
CY2020Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2798000 USD
CY2021Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
628000 USD
CY2020Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
503000 USD
CY2021Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
5798000 USD
CY2020Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
3170000 USD
CY2021Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P7Y11M23D
CY2021Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0607
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
471000 USD
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
2431000 USD
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
2525000 USD
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
2671000 USD
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
2711000 USD
CY2021Q1 csbr Lessee Operating Lease Liabilitytobe Paid After Year Four
LesseeOperatingLeaseLiabilitytobePaidAfterYearFour
10659000 USD
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
21468000 USD
CY2021Q1 us-gaap Due To Related Parties Current And Noncurrent
DueToRelatedPartiesCurrentAndNoncurrent
4000 USD

Files In Submission

Name View Source Status
0001628280-21-004710-index-headers.html Edgar Link pending
0001628280-21-004710-index.html Edgar Link pending
0001628280-21-004710.txt Edgar Link pending
0001628280-21-004710-xbrl.zip Edgar Link pending
csbr-20210131.htm Edgar Link pending
csbr-20210131.xsd Edgar Link pending
csbr-20210131_cal.xml Edgar Link unprocessable
csbr-20210131_def.xml Edgar Link unprocessable
csbr-20210131_htm.xml Edgar Link completed
csbr-20210131_lab.xml Edgar Link unprocessable
csbr-20210131_pre.xml Edgar Link unprocessable
csbrq3131202110-qex311.htm Edgar Link pending
csbrq3131202110-qex312.htm Edgar Link pending
csbrq3131202110-qex321.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending